Among the medicines to be produced at the site will be orforglipron, the company’s oral small-molecule GLP-1 receptor agonist ...

US pharma group says region’s use of ‘one-way insurance system’ to keep down prices is not fair on the industry ...

The new $3 billion manufacturing facility will be sited at the Leiden Bio Science Park in Katwijk, and will be Lilly's first ...

Trump administration pressure on Big Pharma to focus investment on the US has raised concerns in Europe, and specifically the ...

US pharma major Eli Lilly has revealed plans to build a new $3 billion manufacturing facility in Katwijk, the Netherlands, ...

American pharmaceutical company Eli Lilly plans to build a $3bn manufacturing facility at the Leiden Bio Science Park in ...

US-based medicine company Eli Lilly to invest $3B in a new manufacturing facility in the Netherlands to expand production and create jobs.

The facility will be built in the Netherlands and will increase capacity for the company's oral medicines portfolio ...

Indianapolis-based Eli Lilly and Company announced Monday, Nov. 3 that it plans to build a new $3 billion manufacturing ...

Pharmaceutical giant Eli Lilly is demonstrating exceptional market performance, propelled by quarterly results that shattered expectations and a multi-billion dollar expansion initiative. The company ...

Eli Lilly is investing €2.6billion in a new Dutch factory, bringing around 500 jobs and a major boost to the Dutch biotech scene.